Articles tagged with Organoids
The Hippenmeyer group has developed a stable mouse stem cell line and created a robust and reproducible mouse cortical organoid protocol. By comparing developmental stages of the mouse brain with those of the organoids using single-cell sequencing, they found similar cell populations and molecular programs.
A team of researchers has developed a new way to study heart valve disorders by creating miniature, working models of the heart. The models, called assembloids, were grown from pluripotent adult stem cells and can be used to simulate various types of valve disorders, including mitral valve prolapse.
A new open resource of cancer models has enabled researchers to create the first large-scale map of the genes that cancers rely on to survive. The biobank, developed by the Wellcome Sanger Institute and collaborators, reveals potential weak points that could be targeted with future treatments.
The Human Cancer Model Initiative released a compendium of more than 150 organoid models of 25 types of cancer, which are now available to scientists worldwide. These patient-derived organoids provide state-of-the-art research tools for accelerating discovery and developing personalized treatment strategies.
The study presents a novel 3D brain tissue model that accurately replicates the complex interactions in human brain tissue with Alzheimer's disease. The model uses human stem cells to form neurons, astrocytes, and microglial cells, which exhibit key functions similar to those in a real human brain.
A study by the University of Basel reveals how endothelial cells coordinate their cell-cell junctions to form continuous blood vessels. Pushing and pulling forces enable individual vessel segments to connect, allowing for the creation of a highly branched vascular network that supplies the body with oxygen and nutrients.
Research reveals CUDC-907's therapeutic potential in combating glioblastoma by inhibiting PI3K and HDAC, leading to enhanced TMZ sensitivity through disrupted double-strand break repair pathways.
Researchers developed a library of 220 patient-derived tumor organoids, showing promise in screening treatments and recapitulating the tumor immune microenvironment. These models may enable personalized cancer treatment selection, using organoids as avatars during clinical trials.
Researchers created a platform to study chronic pancreatitis pathogenesis and identify potential treatments by generating patient-derived organoids. The organoids revealed consistent dysfunction in the CFTR protein, which may be a future effective therapeutic target.
The Institute for Bioengineering of Catalonia (IBEC) will participate in the ALIVE program, a six-year European grant focusing on the physics of living matter. The project aims to understand how tissues behave by measuring and modeling information flows.
Researchers have developed a new tool to screen genes involved in human development at unprecedented scale and speed. The method, using organoids from human pluripotent stem cells, revealed new insights into human brain development, including the role of ZIC2, SOX11, and ZNF521 genes.
Researchers have developed vascular organoid patches that can regenerate microvessels in the heart, leading to improved heart function and reduced progression of coronary artery disease. The patches were shown to survive for several weeks and stimulate new microvessel formation, providing a potential treatment for ischemic heart disease.
A new device inspired by fish's lateral line senses the pulse of lab-grown heart tissue, enabling real-time monitoring of hundreds of tests. This breakthrough could revolutionize drug screening and personalized medicine with more accurate human tissue simulations.
Researchers developed an AI-powered platform to track drug responses across thousands of patient-derived organoids, enabling real-time monitoring and analysis of tumor heterogeneity. The platform successfully measured how tumor organoids responded to drug treatment, providing a detailed view of treatment responses at the level of indiv...
Researchers found that Ebola virus can persist in cerebral organoids for up to 120 days, infecting various cell types, including neurons and astrocytes. The virus can trigger local inflammation and lead to disease relapses in survivors, highlighting the need for improved treatments.
Researchers at Institute of Science Tokyo have developed a novel culture system to produce stable, scalable, and low-cost clinical-grade intestinal organoids from patient biopsy samples. The innovative approach uses clinical-grade collagen and synthetic peptides to enhance growth and improve scalability.
A new study replicated patient- and sex-specific hallmarks of Inflammatory Bowel Disease (IBD) in a human organ chip, identifying stromal fibroblasts as key drivers of inflammation, fibrosis, and enhanced cancer risk. The model also recapitulated the impact of pregnancy hormones on IBD severity in female patients.
Researchers review organoid-related regulations and progress in IND approval, highlighting the prospects and limitations of organoid models. Organoids are poised to reshape drug research and development with their high clinical relevance, shorter experimental cycles, and lower costs.
Dr. Dilek Colak's journey began with a childhood observation of a boy with mental illness, which inspired her to pursue a career in neuroscience. Her current work focuses on understanding autism and schizophrenia through the study of human brain organoids.
Dr. Aparna Bhaduri receives $750k Pershing Square Sohn Cancer Prize for her innovative glioblastoma research. Her advanced human organoid models reveal how tumors interact with the immune system and brain cells, driving tumor aggressiveness.
Researchers have created lab-grown human skin organoids that can form complex microvascular networks similar to those in native human skin. These self-organizing structures function similarly to native skin, responding to inflammatory stimuli and re-growing after injury.
A new freeze-dried blood product called Thrombosomes has shown promise in treating traumatic brain injuries by reducing swelling and bleeding. The product, derived from platelets with trehalose preservation, has been tested on mice and found to be effective in stabilizing damaged blood vessels.
A new study uses a human stem cell-derived model to identify potential therapies for inflammatory bowel disease (IBD), highlighting glycyrrhizin as a promising candidate. Glycyrrhizin significantly prevents intestinal cell death in both stem cell models and mice with IBD, reducing inflammation and cell death.
Researchers at St. Jude Children's Research Hospital developed patient-derived tumor organoids that accurately reflect the biologic underpinnings of embryonal brain tumors. The models enable faster functional assays and preclinical drug testing without relying on newly obtained tumor samples, advancing the study of pediatric brain tumors.
A team of researchers from Kyoto University has identified multiple types of stromal and secretory cells in the larynx, revealing new insights into vocal fold regeneration. The study's findings provide potential stem cells for treating vocal cord dysfunction and other voice disorders.
A new study by MIT researchers uses advanced human cell cultures to model Rett syndrome, revealing distinct abnormalities caused by two different mutations of the MECP2 gene. The findings suggest that correcting key differences made by each mutation requires different treatments, paving the way for personalized therapies.
STEM Cell Reports has been named the official journal of the 2026 BaCell 3D Organoid Conference in Basel, Switzerland. The conference will bring together leading scientists and experts to share their latest findings on organoid technologies and disease modeling.
Researchers have created a 3D experimental system to study the response of low-grade gliomas to drugs, providing a more realistic environment for testing treatments. The system uses organoids from pluripotent stem cells to replicate glioma development and characteristics.
Researchers developed a new sensor called CAMEO to monitor electrical activity in human cerebral organoids, facilitating research into neurodevelopment and genetic disorders. The device is made of carbon nanotube strands, enabling low-cost and scalable monitoring.
Researchers developed a lab-grown organoid system that faithfully mimics human adrenal gland development and forms complex tissue structures. The system enables the study of adrenal biology, cortisol production in response to stress, and disease development, with potential applications for regenerative therapies.
Researchers at King's College London have developed a new brain organoid system that reduces variability and allows for longer-term recordings of neural activity. The approach enables the simultaneous study of multiple parallel cultures, providing a better understanding of how drugs or gene variants affect neural networks.
Researchers will use human stem cell-based models to uncover molecular and cellular mechanisms underlying autism and schizophrenia. They aim to identify genetic variants that alter brain development and pinpoint common underlying mechanisms for both conditions.
Researchers at Montana State University will study how avian flu viruses impact cells in the chicken intestine to better understand their growth, spread, and propagation. The study aims to find alternative strategies to vaccination, as current vaccines have unclear efficacy and can lead to food safety regulations and trade restrictions.
Scientists at UCSF created a new material that enables more predictable organoid growth, allowing for better study of disease and potential tissue replacement. The dynamic gel, invented by Zev Gartner, mimics the body's soft environment and enables precise 3D printing of stem cells.
Researchers at UC Santa Cruz successfully train brain organoids to balance a virtual pole, demonstrating adaptive learning capabilities. This breakthrough has implications for understanding neurological conditions and developing new tools for studying brain function.
Researchers have developed a new device that can record and stimulate activity across the entire surface of miniature, lab-grown human brain-like tissues, enabling whole-network mapping and manipulation. This breakthrough could improve our understanding of brain development, function, and disease.
Researchers at Johns Hopkins University used lab-grown retinal tissue to discover the cellular mechanisms that shape the foveola, a critical part of the eye responsible for sharp vision. The findings suggest that blue cones convert into red and green cones during early development, rather than migrating to other parts of the retina.
Researchers developed an advanced organoid model for human spinal cord injury and tested a promising regenerative therapy. The treatment triggered neurite growth and reduced scarring in injured organoids, offering validation for its potential to work in humans.
Researchers developed miniature 3D tumor organoid models that closely mimic the human brain, revealing how glioblastoma interacts with surrounding brain cells and immune system. The models identified PTPRZ1 as a key regulator of tumor behavior, which helps determine its aggressiveness.
Researchers created pea-sized mini-stomachs with three main regions, replicating human stomach function and acid secretion. The study models a rare genetic disease, paving the way for personalized treatment and accelerated clinical approval.
The American Association for the Advancement of Science (AAAS) has partnered with Research Networks to publish Computational and Structural Biotechnology Journal, Computational and Structural Biotechnology Reports, and Brain Organoid & Systems Neuroscience Journal as Science Partner Journals. These journals will publish high-quality re...
Dresden researchers have developed a system to test multiple compounds on human pancreatic organoids, identifying 54 compounds that affect pancreas development. These compounds inhibit the GSK3A/B protein and drive progenitor cells to differentiate into functional acinar cells. The ability to generate acinar organoids is valuable for s...
Researchers created lab-grown human nasal tissue to study the defense mechanisms against rhinoviruses. They found that cells in the nasal lining produce interferons, which induce a coordinated antiviral defense, controlling viral replication and reducing damage.
The EMBL-IBEC conference brings together experts to discuss recent breakthroughs in multicellular living systems, including organoids and embryonic development. The event will focus on disease modeling, developmental biology, and regenerative medicine applications.
A Korea University study successfully mimics heart mechanics in organoids using three-dimensional magnetic torque, enhancing cardiac differentiation, maturation, and vascularization. This breakthrough could improve drug safety testing by providing more accurate human-relevant models for cardiotoxicity screening.
A multidisciplinary team of world-leading experts is developing an off-the-shelf engineered product that could address liver failure in millions of patients. The ImPLANT project aims to create synthetic biology-based gene circuits in human induced pluripotent stem cells to drive cell differentiation into all required liver cell types.
Researchers developed a lab-grown model of the prostate gland to study bacterial infections. They found that E. coli targets specific cells and uses a 'lock and key' principle to invade. A sugar molecule called D-mannose blocks this interaction, offering a potential new strategy to prevent and treat prostate infections.
The SPINECRAFT project aims to create a cutting-edge, 4D human spinal cord construct that mirrors the architecture and functionality of the real spinal cord. This platform will enable detailed studies of spinal cord biology and integrate patient-derived cells to recreate disease-specific environments.
Scientists created three-dimensional pancreatic models to study the development of fluid-filled cavities. They found that low pressure and high cell proliferation rates produce complex, star-shaped lumens. The discovery can help understand organ development and diagnose diseases.
Early gastric cancer cells become self-sufficient by producing WNT7B, creating a self-sustaining loop and activating WNT signaling internally. This mechanism is triggered by MAPK signaling activation and has been validated in genetically engineered mouse models and human patient-derived organoids.
Researchers will investigate how HIV and cancer drugs damage brain cells over time, identifying potential early biomarkers of neurotoxicity. They will use human brain organoids grown in the lab to mimic brain physiology.
Dry eye disease affects 5-15% of people, causing symptoms like redness and burning sensation. Researchers generated human tear gland organoids from stem cells to understand the connection between DED and autophagy. They found that disabling autophagy led to cellular disruption, reduced tear protein secretion, and increased cell death.
Researchers at MPI-CBG have created a patient-specific human liver model consisting of three liver cell types, capturing key aspects of human liver physiology in a dish. The novel model provides a platform to study liver diseases, develop new treatments, and advance personalized medicine.
Researchers model Baraitser-Winter syndrome using human brain organoids, finding altered actin genes lead to reduced brain growth and smaller size. The study reveals a single mutation in the cytoskeleton causes disruption in early brain development.
Researchers have identified a new immune function of human M cells, which can process and present gluten antigens, suggesting a potential link to celiac disease. This discovery sheds light on gut immunity and may support future research into celiac disease diagnosis or treatment.
Scientists at Penn Vet have identified two genes, Ctnna1 and Bcl2l13, that suppress metastasis in preclinical models of colorectal cancer. These findings could lead to better treatments and therapies for patients with metastatic disease.
A new retinal organoid platform has identified biomarkers for Leber Congenital Amaurosis (LCA) and allows for genetic testing of patients. The platform uses small 3D structures of retinal cells to classify variants of uncertain significance in LCA genes.
Researchers create a simple, automated way of making lung organoids, which could help test early-stage experimental drugs more effectively. The bioreactor produces larger numbers of organoids with fewer manual labor requirements, offering promise for personalized patient treatments.
Researchers found that early brain firings occur in structured patterns without external experiences, suggesting a genetically encoded blueprint. This discovery can help better understand neurodevelopmental disorders and the impact of toxins on the developing brain.
Researchers at Terasaki Institute and Caltech will use stem cell-based models to identify factors influencing early human development. The goal is to gain insights into infertility, pregnancy loss, and developmental disorders.